Clinical Trial

Protecting Autologous Free Flaps From Ischemia/Reperfusion Damage With Cold Storage.

Study acronym: PAFFIRD
Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 26, 2024 (before its estimated June 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
Reconstructive microsurgery allows autologous transplantation of flaps. The procedure causes temporary ischemia. The absence of perfusion and the post-anastomosis reperfusion causes ischemia/reperfusion (I/R) damage and an increased percentage of flap complications associated with the longer duration of the ischemia time. In reconstructive surgery the utilization of preservation solution is very limited. The research hypothesis is that cold storage of free flaps might offer benefits. The present study is a RCT to evaluate the feasibility and safety of a cold preservation (using the UW solution) of the free flaps from I/R damage in oncological microsurgical reconstructions. Blood perfusion will be intraoperatively evaluated through indocyanine green and SPY-DHI. Moreover, patients' outcomes will be evaluated postoperatively through clinical and radiological examinations, particularly focusing on somatosensory recovery and dental rehabilitation after mandibular reconstruction.
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06523920
Lead Sponsor University of Cagliari
Conditions Ischemia Reperfusion Injury
Enrollment 90 participants
Start Date 2024-08-01
Primary Completion 2025-06-30 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2024-07-26